| The antibodie's description: |
AF6q21 protein, AFX, AFX1, Afxh, FKHR2, FKHRL1, FOXO1, FOXO3, Forkhead box O3, Forkhead box protein O1A, Forkhead box protein O3A, Forkhead box protein O4, Forkhead in rhabdomyosarcoma, Forkhead in rhabdomyosarcoma-like 1, MLLT7, Putative forkhead d antibody, anti-FKHR |
| The antigen used: |
AF6q21 protein, AFX, AFX1, Afxh, FKHR2, FKHRL1, FOXO1, FOXO3, Forkhead box O3, Forkhead box protein O1A, Forkhead box protein O3A, Forkhead box protein O4, Forkhead in rhabdomyosarcoma, Forkhead in rhabdomyosarcoma-like 1, MLLT7, Putative forkhead d antigen, mouse:T24/32, rat:T24/32 FKHR, epitope of the human:T24/32 |
| Gene name: |
AF6q21 protein, AFX, AFX1, Afxh, FKHR2, FKHRL1, FOXO1, FOXO3, Forkhead box O3, Forkhead box protein O1A, Forkhead box protein O3A, Forkhead box protein O4, Forkhead in rhabdomyosarcoma, Forkhead in rhabdomyosarcoma-like 1, MLLT7, Putative forkhead d, FKHR |
| Reactivity: |
mouse:T24/32, rat:T24/32, human:T24/32 |
| Research field: |
Phospho-specific |
| Related products: |
FOXO1/3/4-pan (Phospho-Thr24/32) rabbit polyclonal antibodies |
| Description: |
Freeze thaw will destroy a percentage in every cycle and should be avoided, C in a fridge short term in a concentrated dilution, This antibody needs to be stored at + 4° |
| Properties: |
C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bluegen antibodies they should be stored frozen at - 24° |
| Gene target: |
FOXO1/3/4-pan (Phospho-Thr24/32) |
| Short name: |
anti-FOXO1/3/4-pan (Phospho-Thr24/32) Antibody |
| Technique: |
antibodies against human proteins, antibodies for, antibody to, Antibody |
| Alternative name: |
antibody to-forkhead box O1/3/4-pan (phosphorilated-Thr24/32) (Antibody to) |
| Alternative technique: |
antibodies |
| Alternative to gene target: |
DNA-templated and biological process this GO :0006355 and regulation of transcription, DNA-templated and biological process this GO :0006357 and regulation of transcription from RNA polymerase II promoter and biological process this GO :0006473 and protein acetylation and biological process this GO :0006915 and apoptotic process and biological process this GO :0006974 and cellular response to DNA damage stimulus and biological process this GO :0007173 and epidermal growth factor receptor signaling pathway and biological process this GO :0008286 and insulin receptor signaling pathway and biological process this GO :0008543 and fibroblast growth factor receptor signaling pathway and biological process this GO :0009267 and cellular response to starvation and biological process this GO :0010508 and positive regulation of autophagy and biological process this GO :0031018 and endocrine pancreas development and biological process this GO :0031625 and ubiquitin protein ligase binding and molecular function this GO :0032869 and cellular response to insulin stimulus and biological process this GO :0032873 and negative regulation of stress-activated MAPK cascade and biological process this GO :0034599 and cellular response to oxidative stress and biological process this GO :0035947 and regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter and biological process this GO :0038095 and Fc-epsilon receptor signaling pathway and biological process this GO :0042127 and regulation of cell proliferation and biological process this GO :0042593 and glucose homeostasis and biological process this GO :0043065 and positive regulation of apoptotic process and biological process this GO :0043066 and negative regulation of apoptotic process and biological process this GO :0043565 and sequence-specific DNA binding and molecular function this GO :0045087 and innate immune response and biological process this GO :0045444 and fat cell differentiation and biological process this GO :0045599 and negative regulation of fat cell differentiation and biological process this GO :0045722 and positive regulation of gluconeogenesis and biological process this GO :0045732 and positive regulation of protein catabolic process and biological process this GO :0045892 and negative regulation of transcription, DNA-templated and biological process this GO :0045893 and positive regulation of transcription, DNA-templated and biological process this GO :0045944 and positive regulation of transcription from RNA polymerase II promoter and biological process this GO :0048011 and neurotrophin TRK receptor signaling pathway and biological process this GO :0048015 and phosphatidylinositol-mediated signaling and biological process this GO :0051721 and protein phosphatase 2A binding and molecular function this GO :0070417 and cellular response to cold and biological process this GO :0071455 and cellular response to hyperoxia and biological process this GO :0071732 and cellular response to nitric oxide and biological process this GO :2000505 and regulation of energy homeostasis and biological process, FKH1 and FKHR and FOXO1A, FOXO1 and IDBG-26475 and ENSG00000150907 and 2308, FOXO1 and IDBG-629639 and ENSBTAG00000044105 and 506618, Foxo1 and IDBG-143370 and ENSMUSG00000044167 and 56458, nuclei, protein phosphatase 2A binding, this GO :0000122 and negative regulation of transcription from RNA polymerase II promoter and biological process this GO :0000989 and transcription factor binding transcription factor activity and molecular function this GO :0001078 and RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription and molecular function this GO :0001568 and blood vessel development and biological process this GO :0001659 and temperature homeostasis and biological process this GO :0001678 and cellular glucose homeostasis and biological process this GO :0003677 and DNA binding and molecular function this GO :0003682 and chromatin binding and molecular function this GO :0003700 and sequence-specific DNA binding transcription factor activity and molecular function this GO :0005515 and protein binding and molecular function this GO :0005634 and nucleus and cellular component this GO :0005654 and nucleoplasm and cellular component this GO :0005737 and cytoplasm and cellular component this GO :0005739 and mitochondrion and cellular component this GO :0005829 and cytosol and cellular component this GO :0006351 and transcription, this GO :0000989 : transcription factor binding transcription factor activity, this GO :0000989 : transcription factor binding transcription factor activity and also this GO :0001078 : RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription and also this GO :0003677 : DNA binding and also this GO :0003682 : chromatin binding and also this GO :0003700 : sequence-specific DNA binding transcription factor activity and also this GO :0005515 : protein binding and also this GO :0031625 : ubiquitin protein ligase binding and also this GO :0043565 : sequence-specific DNA binding and also this GO :0051721 : protein phosphatase 2A binding, this GO :0001078 : RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription, this GO :0003677 : DNA binding, this GO :0003682 : chromatin binding, this GO :0003700 : sequence-specific DNA binding transcription factor activity, this GO :0005515 : protein binding, this GO :0031625 : ubiquitin protein ligase binding, this GO :0043565 : sequence-specific DNA binding, this GO :0051721 : protein phosphatase 2A binding, forkhead box O1 |
| Identity: |
3819 |
| Gene: |
FOXO1 |
More about : FOXO1 |
| Long gene name: |
forkhead box O1 |
| Synonyms gene: |
FKHR FOXO1A |
| Synonyms gene name: |
forkhead homolog in rhabdomyosarcoma |
| Synonyms: |
FKH1 |
| Locus: |
13q14, 11 |
| Discovery year: |
1994-01-07 |
| Entrez gene record: |
2308 |
| Pubmed identfication: |
8275086 15057823 |
| RefSeq identity: |
NM_002015 |
| Classification: |
Forkhead boxes |
| Havana BLAST/BLAT: |
OTTHUMG00000016775 |